Position in SRRK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$330,239,916
+$76,537,117 QoQ
Shares Held
6,717,655
+16.6% QoQ
Ownership
5.61%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 90.4254386389298.ToString("F0")%
None 9.574561361070195.ToString("F0")%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. SRRK ranks #14 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in SRRK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $330,239,916 | 6,717,655 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $253,702,799 | 5,759,428 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $169,288,827 | 4,545,887 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $71,720,713 | 2,024,865 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $59,316,650 | 1,844,997 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $74,581,379 | 1,725,622 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,600,213 | 199,777 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,432,559 | 171,976 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,793,309 | 157,281 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,346,831 | 71,640 | Shares | Defined | 2024-02-12 | |
| 2023-03-31 | $2,071,992 | 258,999 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,443,852 | 270,039 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,882,866 | 271,698 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $716,565 | 130,522 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,682,428 | 130,522 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $30,703,481 | 1,236,050 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $42,149,632 | 1,276,488 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,405,286 | 567,657 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $16,252,080 | 320,807 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $12,341,663 | 254,310 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,316,852 | 300,557 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||